RAPT Therapeutics Inc. (RAPT)

RAPT trades at $30.14, 100.9% above the near-term max pain of $15 expiring Oct 17, 2025 (13 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$22.5), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for RAPT shows a downward trend from 22.5 to 2.5, indicating bearish sentiment or hedging activity. The 182% spread signals divergent expectations across timeframes. Most levels below 30.14 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.